These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12066578)

  • 1. Modifying the release of gentamicin from microparticles using a PLGA blend.
    Friess W; Schlapp M
    Pharm Dev Technol; 2002 May; 7(2):235-48. PubMed ID: 12066578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release mechanisms from gentamicin loaded poly(lactic-co-glycolic acid) (PLGA) microparticles.
    Friess W; Schlapp M
    J Pharm Sci; 2002 Mar; 91(3):845-55. PubMed ID: 11920769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterilization of gentamicin containing collagen/PLGA microparticle composites.
    Friess W; Schlapp M
    Eur J Pharm Biopharm; 2006 Jun; 63(2):176-87. PubMed ID: 16497493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of polymer blending on the release of ganciclovir from PLGA microspheres.
    Duvvuri S; Gaurav Janoria K; Mitra AK
    Pharm Res; 2006 Jan; 23(1):215-23. PubMed ID: 16320000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
    Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
    Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres.
    Prior S; Gander B; Blarer N; Merkle HP; Subirá ML; Irache JM; Gamazo C
    Eur J Pharm Sci; 2002 Mar; 15(2):197-207. PubMed ID: 11849917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice.
    Lecaroz MC; Blanco-Prieto MJ; Campanero MA; Salman H; Gamazo C
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1185-90. PubMed ID: 17220415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of PLGA End Groups on the Release Profile of Dexamethasone from Ocular Implants.
    Saraf I; Kushwah V; Alva C; Koutsamanis I; Rattenberger J; Schroettner H; Mayrhofer C; Modhave D; Braun M; Werner B; Zangger K; Paudel A
    Mol Pharm; 2023 Feb; 20(2):1307-1322. PubMed ID: 36680524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres.
    Ravivarapu HB; Burton K; DeLuca PP
    Eur J Pharm Biopharm; 2000 Sep; 50(2):263-70. PubMed ID: 10962237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells.
    Walter E; Dreher D; Kok M; Thiele L; Kiama SG; Gehr P; Merkle HP
    J Control Release; 2001 Sep; 76(1-2):149-68. PubMed ID: 11532321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic polymer matrix for the delayed or pulsatile release of water-soluble peptides.
    Schachter DM; Kohn J
    J Control Release; 2002 Jan; 78(1-3):143-53. PubMed ID: 11772456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Often neglected: PLGA/PLA swelling orchestrates drug release: HME implants.
    Bode C; Kranz H; Fivez A; Siepmann F; Siepmann J
    J Control Release; 2019 Jul; 306():97-107. PubMed ID: 31150749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of release rate of tetanus vaccine from polyester microspheres.
    Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R
    Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
    Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
    Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
    Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
    J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen/PLGA microparticle composites for local controlled delivery of gentamicin.
    Schlapp M; Friess W
    J Pharm Sci; 2003 Nov; 92(11):2145-51. PubMed ID: 14603500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer erosion in PLGA microparticles produced by phase separation method.
    Husmann M; Schenderlein S; Lück M; Lindner H; Kleinebudde P
    Int J Pharm; 2002 Aug; 242(1-2):277-80. PubMed ID: 12176263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.